Zakikhani, Mahvash

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

Zakikhani, M., Dowling, R., Fantus, I. G., Sonenberg, N., & Pollak, M. (2006) · Cancer Research

Metabolism, Diabetes, and CancerPI3K/AKT/mTOR signaling in cancer

Cited by 1,048

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research

Metabolism, Diabetes, and CancerPI3K/AKT/mTOR signaling in cancer

Cited by 933

Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells

Zakikhani, M., Blouin, M.-J., Piura, E., & Pollak, M. N. (2010) · Breast Cancer Research and Treatment

Metabolism, Diabetes, and CancerPI3K/AKT/mTOR signaling in cancer

Cited by 213

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth

Algire, C., Zakikhani, M., Blouin, M.-J., Shuai, J. H., & Pollak, M. (2008) · Endocrine Related Cancer

Metabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism

Cited by 185

Serine deprivation enhances antineoplastic activity of biguanides

Gravel, S.-P., Hulea, L., Toban, N., Birman, E., Blouin, M.-J., Zakikhani, M., Zhao, Y., Topisirovic, I., St-Pierre, J., & Pollak, M. (2014) · Cancer Research

Metabolism, Diabetes, and CancerCancer, Hypoxia, and Metabolism

Cited by 138